MARKER THERAPEUTICS, INC. Property, Plant and Equipment, Gross
MARKER THERAPEUTICS, INC. (MRKR) had Property, Plant and Equipment, Gross of $17.79 million as of 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2023-05-15
- 2023-03-31: Property, Plant and Equipment, Gross $17.79M.
- 2022-12-31: Property, Plant and Equipment, Gross $17.60M.
- 2022-09-30: Property, Plant and Equipment, Gross $17.73M.
- 2022-06-30: Property, Plant and Equipment, Gross $17.64M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2023-03-31 | $17.79M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $17.60M 10-Q · filed 2023-05-15 |
| 2022-09-30 | $17.73M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $17.64M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $13.59M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $12.84M 10-K · filed 2023-03-22 |
| 2021-09-30 | $12.02M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $11.73M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $11.39M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $4.16M 10-K · filed 2022-03-17 |
| 2020-09-30 | $3.01M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $1.82M 10-Q · filed 2020-08-10 |
| 2019-12-31 | $523.00K 10-K · filed 2021-03-09 |
| 2019-09-30 | $510.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $453.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $371.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $148.00K 10-K · filed 2020-03-12 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |